MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, today presented new pre-clinical data for its lead RNA activation program for the treatment of sickle cell disease, ...

Researchers at the meeting reported on long-term activity of commercialized gene therapies and preliminary data on ...

Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...

DATA PRESENTATIONS AT ASH 2024 Updated data from the Company’s lentiviral vector (LVV) gene addition programs in patients with sickle cell disease who have a history of vaso-occlusive events and ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...

Medical experts and thalassemia advocates are urging the Indian government to mandate nucleic acid amplification testing (NAT) for blood safety, create a national thalassemia control program ...

Thalassemia is an inherited blood condition. When you have it, your body has fewer red blood cells and less of a protein called hemoglobin than it should. Hemoglobin is important because it lets ...

The scientists suggest that if the reversal of glutamine metabolism does not occur, the result may be blood diseases such as β-thalassemia. Detailed findings appeared in Science, in an article ...

This fundamental biologic process is defined by a series of complex metabolic processes, which are often dysregulated in blood disorders such as sickle cell disease and β-thalassemia. St. Jude ...

Hyderabad: In a noble gesture, the All India Payam e Insaniyat Foundation organized mega voluntary Blood Donation Camp for Thalassemia patients, especially children at Malakpet on Monday. A total of ...

NEW DELHI: Medical experts and patient advocacy groups have urged the govt to make nucleic acid amplification testing (NAT) mandatory for blood safety to protect thalassemia patients and all ...